Clinical Trial Update: Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis) [Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase study of allogeneic adipose-derived mesenchymal stem cell transplantation for idiopathic nephrotic syndrome …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis
• Nephrotic Syndrome

Drugs mentioned

• Allogeneic adipose-derived mesenchymal stem cells (allogeneic adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Focal Segmental Glomerulosclerosis | Phase 1 | Status: UNKNOWN